Results 151 to 160 of about 87,767 (313)
Emerging imaging modalities for the diagnosis of malignant lesions of the male reproductive tract in companion animals. [PDF]
Gomes DR +7 more
europepmc +1 more source
Prostate cancer is immunologically ‘cold’, with scarce, dysfunctional type 1 conventional dendritic cells (cDC1s) that limit T cell priming. We introduce an aptamer‐targeted liposomedelivering FMS‐like tyrosine kinase 3 ligand (Flt3L) and chlorin e6 (Ce6). Ultrasound induces antigen release and cDC1s recruitment, creating an in situ cDC1 vaccine.
Jiayi Wang +8 more
wiley +1 more source
Two faces of malignancy in one prostate: A rare coexistence of adenocarcinoma and leiomyosarcoma. [PDF]
Tran TT +4 more
europepmc +1 more source
The FAK‐STAT3‐NNMT axis drives anoikis resistance in circulating tumor cells by reprogramming fatty acid oxidation. Targeting this metabolic vulnerability suppresses metastasis, untangling a key mechanism of breast cancer progression and revealing NNMT as a promising therapeutic target.
Qingchao Tong +13 more
wiley +1 more source
Primary prostatic yolk sac tumor: A rare case report and literature review. [PDF]
Shi M, Ren G, Zhang Y, Zhang Y.
europepmc +1 more source
Local and Systemic Effects of Chronic Intracavernous Injection of Papaverine, Prostaglandine E1 and Saline in Primates [PDF]
Aboseif, Sherif R. +7 more
core
This review surveys nanoparticle‐based strategies to enhance adoptive cell therapy, particularly CAR‐T cell approaches, in solid tumor treatment. It describes how nanoparticles can improve tumor immunogenicity and T‐cell infiltration while reducing toxicity, and how they enable in vivo CAR‐T cell generation.
Erica Frostegård +19 more
wiley +1 more source
Pretherapeutic <sup>18</sup>F-PSMA PET/CT Reveals Incidental Tracheal Epithelial-Myoepithelial Carcinoma. [PDF]
Gossili F, Fuentes-Martinez N, Høyer C.
europepmc +1 more source
Prostate cancer remains a leading cause of male cancer death, yet screening cannot reliably identify aggressive disease, underscoring the need for tissue biomarkers. It is shown that primary tumors increase ER–plasma membrane junction signaling via STIM1/ORP5, whereas metastasis features their loss, Golgi dispersal, and rapid conversion of high‐mannose
Amanda J. Macke +14 more
wiley +1 more source

